Tweet
https://losangeles.cbslocal.com/2021...ancer-therapy/
Eleven-Year-Old Boy With Rare Cancer Is Youngest Patient To Receive Gene Targeted Cancer Therapy
By CBSLA Staff September 22, 2021 at 5:04 pm
SANTA MONICA (CBSLA) – A Seattle father brought his son to Santa Monica in hopes of one thing: finding a cure for his 11-year-old son who is battling a rare form of cancer.
Kian Faghih was diagnosed with rhabdomyosarcoma (RMS), a cancer of the heart and skeletal muscle which originated from another part of his body and has now spread to his lungs.
“At the end they said that there is no cure for him and we cannot do anything for him. That’s why we started looking,” Jamshid Faghih, Kian’s father said.
Kian has battled with cancer for two and a half years. After being told that there were no other options, his father found Dr. Erlinda Gordon from the Sarcoma Oncology Center in Santa Monica. The Faghihs reached out to Dr. Gordon to see if Kian could receive an experimental treatment she created called, DeltaRex-G, an innovative gene-targeted cancer therapy...
Eleven-Year-Old Boy With Rare Cancer Is Youngest Patient To Receive Gene Targeted Cancer Therapy
By CBSLA Staff September 22, 2021 at 5:04 pm
SANTA MONICA (CBSLA) – A Seattle father brought his son to Santa Monica in hopes of one thing: finding a cure for his 11-year-old son who is battling a rare form of cancer.
Kian Faghih was diagnosed with rhabdomyosarcoma (RMS), a cancer of the heart and skeletal muscle which originated from another part of his body and has now spread to his lungs.
“At the end they said that there is no cure for him and we cannot do anything for him. That’s why we started looking,” Jamshid Faghih, Kian’s father said.
Kian has battled with cancer for two and a half years. After being told that there were no other options, his father found Dr. Erlinda Gordon from the Sarcoma Oncology Center in Santa Monica. The Faghihs reached out to Dr. Gordon to see if Kian could receive an experimental treatment she created called, DeltaRex-G, an innovative gene-targeted cancer therapy...
Comment